In addition, increase polymorphism-mutations in MTR 2756, total MTHFR deficiency, and DHFR 19bp in BC group (Figure 1A and 1B) support the evidence on the aberrant modulation of DNA methylation by gene polymorphisms involved with the OCM. This evidence concerns the gene MTR and breast cancer.